Prevalence and characteristics of persistent pain among head and neck cancer survivors: a systematic review and meta-analysis - Top-Institutions - MDSpire

Prevalence and characteristics of persistent pain among head and neck cancer survivors: a systematic review and meta-analysis

  • By

  • Miguel Ángel Fernández-Gualda

  • Paula Postigo-Martin

  • Maria Fernandez-Gonzalez

  • Lydia Martin-Martin

  • Pilar Vargas-Arrabal

  • Mario Lozano-Lozano

  • Carolina Fernández-Lao

  • April 28, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Head and Neck Oncology
    • Pain Management
    • Cancer Survivorship

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Head and Neck Oncology
    • Pain Medicine
    • Palliative Care

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Pain Research
    • Cancer Survivorship

  • #4

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Head and Neck Surgery
    • Pain Medicine
    • Cancer Survivorship

  • #5

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Head and Neck Oncology
    • Pain Management
    • Rehabilitation Medicine

Original Source(s)

Prevalence and characteristics of persistent pain among head and neck cancer survivors: a systematic review and meta-analysis

  • by Miguel Ángel Fernández-Gualda, Paula Postigo-Martin, Maria Fernandez-Gonzalez, Lydia Martin-Martin, Pilar Vargas-Arrabal, Mario Lozano-Lozano, Carolina Fernández-Lao

  • April 28, 2025

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer